- Home
- PPBT vs TWAV Comparison
PPBT vs TWAV Comparison
Compare PPBT & TWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PPBT | TWAV |
|---|---|---|
| Founded | 2010 | N/A |
| Country | Israel | United States |
| Employees | N/A | 7 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9M | 4.2M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | PPBT | TWAV |
|---|---|---|
| Price | $4.05 | $1.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $30.00 | N/A |
| AVG Volume (30 Days) | 8.7K | ★ 869.7K |
| Earning Date | 05-20-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $0.58 |
| 52 Week High | $5.18 | $2.41 |
Technical Indicators
Market Signals| Indicator | PPBT | TWAV |
|---|---|---|
| Relative Strength Index (RSI) | 60.47 | 56.74 |
| Support Level | $3.63 | $0.58 |
| Resistance Level | $4.39 | $1.81 |
| Average True Range (ATR) | 0.30 | 0.20 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 68.53 | 50.88 |
Price Performance
Historical ComparisonAbout PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
About TWAV TaoWeave Inc. Common Stock
TaoWeave Inc is a digital asset company. The company offers investors a regulated, publicly traded vehicle to gain exposure to the decentralized AI economy. The company aims to invest in the Bittensor ecosystem through partnerships with subnets, miners, and validators, amd operates with zero debt by maintain appropriate cash reserves.